NCT01565330View on ClinicalTrials.gov

A Study of Two Doses of 18F-AV-45 in Alzheimer's Disease and Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Alzheimer Disease
Interventions
DRUG

florbetapir F 18

single dose IV injection

Trial Locations (3)

21901

Research Site, North East

33407

Research Site, West Palm Beach

08021

Research Site, Clementon

Sponsors
All Listed Sponsors
lead

Avid Radiopharmaceuticals

INDUSTRY